Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis.

CONCLUSIONS: In patients with sepsis, SAC is associated with higher 28-day mortality. The administration of rhsTM reduced 28-day mortality in patients with SAC, but not in those without SAC. PMID: 32237269 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32237269?dopt=Abstract

Source: Thrombosis and Haemostasis - March 31, 2020 Category: Hematology Authors: Valeriani E, Squizzato A, Gallo A, Porreca E, Vincent JL, Iba T, Hagiwara A, Di Nisio M Tags: J Thromb Haemost Source Type: research

More News: Bleeding | Hematology | Study | Thrombosis